Dexmedetomidine shows anaesthetic benefits in endotoxaemic horses
Bottom line
Dexmedetomidine may offer a meaningful hemodynamic advantage for horses that are already endotoxaemic when they go under general anaesthesia, according to a new randomized controlled study in Equine Veterinary Journal. In the experiment, 10 healthy horses received IV E. coli lipopolysaccharide immediately before anaesthesia, then were assigned to either xylazine or dexmedetomidine during sevoflurane anaesthesia. Horses in the dexmedetomidine group had higher cardiac index at 30 and 60 minutes, maintained normal creatinine concentrations while the xylazine group’s creatinine rose from 90 minutes onward, and showed improved base excess later in the anaesthetic period. Cytokine concentrations were similar between groups, suggesting the observed benefit was primarily cardiovascular and renal rather than a measurable anti-cytokine effect in this model. (eurekamag.com)
Why it matters: Endotoxaemia remains a major perioperative problem in equine colic and other critically ill patients, with risks that include cardiovascular instability, renal compromise, and downstream complications such as laminitis. This study builds on earlier work from the same research line showing dexmedetomidine could improve cardiopulmonary function and intestinal blood flow in experimentally endotoxaemic horses under anaesthesia, but extends the finding to a tougher clinical scenario: endotoxaemia established before anaesthetic induction. For equine veterinarians, the practical signal is that dexmedetomidine-based balanced anaesthesia, paired with reduced inhalant requirement, may help support perfusion in select high-risk cases, although the authors note the protocol does not represent all surgical colics and the sample size was small. (madbarn.com)
What to watch: The next question is whether these experimental findings translate into better outcomes, fewer complications, or protocol changes in clinical colic and endotoxaemic surgical patients. (eurekamag.com)
Key facts
- Study type
- Randomized controlled study
- Journal
- Equine Veterinary Journal
- Sample size
- 10 healthy horses
- Model
- IV E. coli O55:B5 lipopolysaccharide given immediately before anaesthesia
- Comparison
- Xylazine versus dexmedetomidine during sevoflurane anaesthesia
- Key finding
- Dexmedetomidine group had higher cardiac index at 30 and 60 minutes
- Renal finding
- Creatinine stayed normal with dexmedetomidine, but rose in the xylazine group from 90 minutes onward
- Other finding
- Base excess was improved later in anaesthesia with dexmedetomidine
- Limitation
- Small sample size, and the protocol was not representative of all surgical colics
A new Equine Veterinary Journal study suggests dexmedetomidine infusion may improve cardiovascular performance and preserve renal function in anaesthetised horses that are already endotoxaemic at the time of induction. In a randomized controlled experiment, investigators compared dexmedetomidine with xylazine in horses given IV lipopolysaccharide immediately before anaesthesia and found better cardiac index, more favorable acid-base status, and lower creatinine values in the dexmedetomidine group. (eurekamag.com)
That matters because endotoxaemia is one of the defining physiologic challenges in equine emergency and surgical care, especially in horses with gastrointestinal disease. Horses are notably sensitive to endotoxin exposure, and the resulting inflammatory and circulatory changes can contribute to hypotension, poor tissue perfusion, kidney injury, and complications such as laminitis. Managing those patients under inhalant anaesthesia is especially difficult because anaesthetic drugs can further depress cardiovascular function. (petmd.com)
The new study included 10 systemically healthy horses that were instrumented for thermodilution-based cardiac index monitoring. All horses received IV E. coli O55:B5 lipopolysaccharide at 0.1 μg/kg immediately before anaesthesia. The control group received xylazine, while the treatment group received dexmedetomidine at 1.75 μg/kg/hour IV; the dexmedetomidine group was also maintained at a lower target end-tidal sevoflurane concentration, 1.8% versus 3% in controls. Investigators assessed cardiopulmonary variables, acid-base status, cytokines, and creatinine every 30 minutes for 180 minutes. (eurekamag.com)
The headline findings were clinically relevant. Mean cardiac index was significantly higher with dexmedetomidine at both 30 and 60 minutes. Creatinine stayed within normal limits in the dexmedetomidine group but was elevated and significantly higher in the xylazine group from 90 minutes onward, reaching 201 ± 38 μmol/L versus 124 ± 26 μmol/L at 180 minutes. Base excess was also significantly improved later in anaesthesia in the dexmedetomidine group. Cytokine concentrations, however, did not differ between groups. The authors concluded that dexmedetomidine infusion, together with reduced inhalant anaesthetic requirement, could benefit anaesthetic management even when endotoxaemia is already established. (eurekamag.com)
The work also fits into a broader body of equine dexmedetomidine research. A 2021 study from related investigators reported improved systemic and intestinal hemodynamics in experimentally endotoxaemic horses receiving dexmedetomidine during sevoflurane anaesthesia. Other published work has described dexmedetomidine as an attractive agent in horses because its pharmacokinetic and pharmacodynamic profile supports constant-rate infusion use, and prior equine anaesthesia studies have shown inhalant-sparing and cardiopulmonary effects that make it relevant to balanced anaesthesia protocols. (madbarn.com)
Why it matters: For veterinary professionals, the key takeaway is not that dexmedetomidine is now a universal answer for endotoxaemic horses, but that it may be a useful tool in anaesthetic planning for select high-risk equine patients. The likely mechanism here is at least partly hemodynamic: better perfusion and lower inhalant exposure, rather than a clear reduction in circulating inflammatory mediators in this model. That distinction is important in practice. It suggests dexmedetomidine may help stabilize anaesthesia and protect organ perfusion during a vulnerable window, but clinicians still need comprehensive endotoxaemia management, including fluid therapy, anti-inflammatory treatment, and close monitoring of cardiovascular and renal parameters. The study’s limitations are also notable: only 10 horses were included, the model used experimentally induced endotoxaemia in otherwise healthy animals, and the authors explicitly cautioned that the protocol is not representative of all surgical colics. (eurekamag.com)
What to watch: The next step will be whether clinical studies in naturally occurring colic, sepsis, or perioperative endotoxaemia confirm improved outcomes, not just better short-term physiologic markers, and whether those data are strong enough to shift equine anaesthesia protocols in referral and hospital settings. (eurekamag.com)